- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
SBSG
VIE
Week ended 07 Aug 2026
Weekly Investor Report
Stratec SE · Healthcare · Medical Devices
Latest close
20.40 EUR
3.4%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 7.5% above the Trend Line and sits at 26.9% of its 52-week range. The latest completed week returned 3.4%, after a 6.4% four-week move. The latest news-sentiment score is 50/100.
Setup score
39
out of 100
Latest Close
20.40 EUR
7 Aug 2026
1W Return
3.4%
latest completed week
4W Return
6.4%
short-term follow-through
12W Return
25.1%
quarterly tape
Trend Breadth
7.7%
4 of 52 weeks active
Volume Ratio
1.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.4%
Latest completed week; four-week move 6.4%.
Indicator stack
4/68
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 7.5% above the Trend Line and sits at 26.9% of its 52-week range. The latest completed week returned 3.4%, after a 6.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3312-week average 0.21
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.33Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 6.4% over four weeks, 25.1% over 12 weeks, and -25.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year4
Trend breadth7.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.81Latest activity-pressure read.
Pressure change43.8%Four-week change in activity pressure.
Leadership-23.94Latest relative-leadership reading.
RS change22.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-37.5%Distance below the 52-week high.
13-week volatility3.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2611 weeks finished lower.
Best week+11.6%Week of 17 Apr.
Worst week-9.7%Week of 24 Apr.
Latest week+3.4%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains11
Flat weeks1
Modest losses5
Sharp losses6
Recent vol3.1%13-week weekly-return volatility.
Base vol5.7%52-week weekly-return volatility.
Up/down split25/25Count of positive and negative weeks in the 52-week window.
Average skew4.1% / -4.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank- / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Medical Devices
4-week rank8 / 15
Group average6.7%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD86.7%positive activity pressure
RS13.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape31/100
Trend, activity pressure, participation, and risk combine to a 31/100 tape read.
Indicator analysis27/100Latest 12-week confirmation: trend 0/12, activity pressure 7/12, relative leadership 0/12.
Activity pressure 0.33; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 20.40 EUR | 3.4% | 18.98 EUR | 22.58 EUR | 0.81 | -23.94 | 576 | Off |
| 31 Jul 2026 | 19.72 EUR | 0.6% | 19.10 EUR | 22.61 EUR | 0.76 | -25.23 | 0 | Off |
| 24 Jul 2026 | 19.60 EUR | -0.2% | 19.18 EUR | 22.65 EUR | 0.75 | -26.70 | 109 | Off |
| 17 Jul 2026 | 19.64 EUR | 2.4% | 19.27 EUR | 22.69 EUR | 0.72 | -26.62 | 2.2K | Off |
| 10 Jul 2026 | 19.18 EUR | 5.3% | 19.36 EUR | 22.74 EUR | 0.57 | -30.73 | 0 | Off |
| 3 Jul 2026 | 18.22 EUR | 3.5% | 19.45 EUR | 22.79 EUR | 0.46 | -35.94 | 0 | Off |
| 26 Jun 2026 | 17.60 EUR | -0.3% | 19.61 EUR | 22.86 EUR | 0.10 | -37.51 | 0 | Off |
| 19 Jun 2026 | 17.66 EUR | 1.2% | 19.78 EUR | 22.94 EUR | -0.04 | -39.31 | 0 | Off |
| 12 Jun 2026 | 17.45 EUR | 5.9% | 19.85 EUR | 23.02 EUR | -0.38 | -38.15 | 0 | Off |
| 5 Jun 2026 | 16.48 EUR | -3.4% | 19.98 EUR | 23.10 EUR | -0.76 | -40.57 | 0 | Off |
| 29 May 2026 | 17.06 EUR | 2.7% | 20.10 EUR | 23.21 EUR | -0.80 | -39.94 | 1.6K | Off |
| 22 May 2026 | 16.62 EUR | 1.9% | 20.32 EUR | 23.31 EUR | -1.00 | -40.73 | 200 | Off |
| 15 May 2026 | 16.31 EUR | -5.4% | 20.64 EUR | 23.42 EUR | -0.99 | -41.36 | 0 | Off |
| 8 May 2026 | 17.24 EUR | 1.6% | 21.01 EUR | 23.54 EUR | -0.77 | -38.95 | 526 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.